Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
